The interaction of Nac1 with Miz1 leads to the recruitment of Miz1 into Nac1 nuclear bodies, and the artificial knock-down of Nac1 in an ovarian cancer cell line results in increased levels of the Miz-1 target gene product, p21Cip1. The gene discussed is CDKN1A; the disease is ovarian cancer.